Introduction Obesity is a major risk factor for cardiovascular disease, diabetes, osteoarthritis,
and some cancers. Weight loss is an obvious management for this, but a major problem is …

Liraglutide Produces Clinically Significant Weight Loss in Nondiabetic Patients, But At What
Cost? | Journal of Clinical Outcomes Management Skip to main content Home Journal of …

Introduction: Obesity is a global health challenge, and pharmacologic options are emerging.
Once daily subcutaneous administration of 3 mg liraglutide, a glucagon like peptide-1 …

Importance Weight loss of 5% to 10% can improve type 2 diabetes and related
comorbidities. Few safe, effective weight-management drugs are currently available …

Background Obesity is a chronic disease with serious health consequences, but weight loss
is difficult to maintain through lifestyle intervention alone. Liraglutide, a glucagon-like …

Liraglutide has been studied in several clinical trials evaluating its effectiveness, tolerability,
and safety in overweight and obese individuals.(Appendix 1 available online at https://wchh …

Objective: As an adjunct to a reduced-calorie diet and increased physical activity, treatment
with liraglutide 3.0 mg for weight management provides a statistically significant and …

Background The frequency of obesity has risen dramatically in recent years but only few
safe and effective drugs are currently available. We assessed the effect of liraglutide on …

Background As the pandemic of obesity presents an increasing serious health challenge
worldwide, additional medical interventions, especially pharmacotherapy, should be …

OBJECTIVE: To review the efficacy and safety of liraglutide 3.0 mg for weight loss. DATA
SOURCE: A literature search was performed using PubMed and MEDLINE from 2000 to …